Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO)
暂无分享，去创建一个
V. Zagonel | M. Eoli | M. Michiara | G. Lombardi | E. Anghileri | M. Caccese | G. Cerretti | M. Simonelli | C. Caserta | R. Rudà | A. Pellerino | S. Rizzato | M. Padovan